Navigation Links
Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
Date:5/2/2013

represents adjusted net revenue less

adjusted cost of sales and excludes amortization of acquired

intangibles. Pro forma adjustments for the respective periods

include the following: Adjustment for contract revenue realized at fair value (product sales)

$
4.8$
-Manufacturing and supply contract termination payment (other revenue)

5.0-Acquisition accounting adjustments (cost of sales)

93.5-Acquisition, integration and restructuring

1.0-Operational Excellence Initiative

6.31.7 

Actavis Pharma net revenue, which consists of sales of generics, branded generics and OTC products in the Americas (United States, Canada and Latin America), Europe (Europe, Russia, CIS and Turkey), and the Middle East, Africa, Australia and Asia Pacific (collectively, MEAAP), for the first quarter 2013 increased 37 percent to $1.5 billion primarily due to the acquisition of the Actavis Group in late 2012.  First quarter international net revenue was $608.6 million, up 254 percent from the prior year, primarily as a result of the inclusion of legacy Actavis product sales.  This increase was offset in part by lower sales of the generic version of Lipitor® due to the loss of exclusivity in 2012.

Actavis Pharma R&D investment for the first quarter 2013 increased to $98.8 million and selling and marketing expenses for the first quarter 2013 increased to $159.3 million primarily as a result of the inclusion of legacy Actavis results.

Actavis Pharma's adjusted gross margin increased from 45.1 percent in the first quarter of 2012 to 50.7 percent in the first quarter of 2013, primarily due to the distribution of Lidoderm® and increased margins on our generic version of Concerta® as a result of our contractual arrangement with Ortho-McNeil-Janssen. The prior year gross margin was negatively impacted by higher sales of generic Lipitor® at lower margins.

 
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
2. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
3. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
4. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
5. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
6. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
7. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
8. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
9. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
10. Watson Announces New Name -- Actavis -- for Global Operations
11. Watson and Actavis Receive FTC Second Request
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Registration is officially open for MEDTEC China ... at the Shenzhen Convention & Exhibition Center. The ... to join the MEDTEC China family of events. MEDTEC China ... to better serve the South China ... an important region for China,s medical ...
(Date:3/3/2015)... Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., a ... islet replacement therapy for the treatment of diabetes in ... Eugene Brandon , Director of Strategic Relations and Project ... showcases the latest in type 1 diabetes management technology ... as follows: , , , Title:   , ...
(Date:3/3/2015)... and NEW YORK , March 3, ... ), a biopharmaceutical company advancing protein biologic therapies and ... at the 27 th Annual ROTH Capital Partners ... at The Ritz-Carlton, Laguna Niguel in Dana Point, California.  ... Wehner , is scheduled to present a corporate update ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3ViaCyte to Present at JDRF TypeOneNation Research Summit 2PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference 2
... , WALTHAM, Mass., Nov. ... authority on medical technology market intelligence, policy changes made by ... a surge in obstructive sleep apnea (OSA) diagnostic testing and ... Sleep Management Devices 2010 report finds that increasing reimbursement ...
... Nov. 16 Epilepsy and seizures affect nearly 3 million Americans ... cause is apparent. Those who live daily with the condition have ... long it will last or where they will be, often experiencing ... The wonder behind the diagnosis, the perseverance in managing it, ...
Cached Medicine Technology:Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 5
(Date:3/3/2015)... Chicago, Il. (PRWEB) March 03, 2015 ... – is set to reveal the world’s first fully ... you are breathing and controls an air purifier to ... the user informed, and in control, via phone, tablet ... air purifiers in over 50 countries worldwide, will unveil ...
(Date:3/3/2015)... In March, 1% for the Planet ... off a new campaign, “Know Your Source,” which calls for ... ambassadors in their quest for ingredient awareness and better business ... its members and partners, including King Arthur Flour, Good Culture, ... raise awareness for food as an environmental issue, with a ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois ... pleased to announce that all Rabbit brand air purifiers are ... the west coast port strikes. This news comes just in ... , The port strikes, which have caused significant ... economic growth by as much as 1%, have hindered the ...
(Date:3/3/2015)... March 03, 2015 Topical BioMedics, Inc., announces ... webinar streamed live on Tuesday, March 10th, 12pm – 1pm ... archived and accessible 24/7. , The Pain ... topic for the March 10th workshop is “Opioid Addiction: ... that the U.S. represents 5% of the world’s population, yet ...
(Date:3/3/2015)... The combinatorial, multi-gene GeneSight test ... outcomes for patients with depression, and their use ... individual genes that comprise the test, according to ... Clinic and Assurex Health, and published online by ... technology of the GeneSight Psychotropic test is based ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6
... ... Warady & Davis LLP, Certified Public Accountants & Consultants, as one of the ... University" training program, flexible scheduling, great team atmosphere built on friendships and many perks. ... Deerfield, IL ...
... Swedish researchers found that rheumatoid arthritis (RA) patients did ... 6 years after starting anti-tumor necrosis factor (TNF) therapy. ... Ph.D., from Karolinska University Hospital in Stockholm, Sweden assessed ... using anti-TNF therapies: infliximab, adalimumab, and etanercept. Details ...
... Realty Trust, Inc. (NYSE: BMR ), a real estate ... Science Industry®, today announced operating and financial results for the ... http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO ) , Highlights: , Increased total ... from $80.8 million for the same period in 2008. ...
... , WASHINGTON, Oct. 28 Trust for America,s ... a new ad campaign today entitled Health Care vs. ... reform provides a once-in-a-lifetime chance to transform our health care ... prevention and wellness," said Jeff Levi, PhD, Executive Director of ...
... ROCKVILLE, Md., Oct. 28 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of clinical-stage product candidates for ... results for the quarter ended September 30, 2009, on ... full text copy of the release will be disseminated ...
... CSV ) today announced results for the third quarter ended September 30, 2009. Financial highlights from continuing operations for the third ... Results, (amounts in millions, except per share amounts), ... ... ...
Cached Medicine News:Health News:Warady & Davis LLP Named One of 'Top 50 Employers for Generation Y Chicago' 2Health News:Warady & Davis LLP Named One of 'Top 50 Employers for Generation Y Chicago' 3Health News:Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients 2Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 2Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 3Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 4Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 5Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 6Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 7Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 8Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 9Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 10Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 11Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 12Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 13Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 14Health News:BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 15Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 2Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 3Health News:Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009 2Health News:Carriage Services Announces Third Quarter 2009 Results 2Health News:Carriage Services Announces Third Quarter 2009 Results 3Health News:Carriage Services Announces Third Quarter 2009 Results 4Health News:Carriage Services Announces Third Quarter 2009 Results 5Health News:Carriage Services Announces Third Quarter 2009 Results 6Health News:Carriage Services Announces Third Quarter 2009 Results 7Health News:Carriage Services Announces Third Quarter 2009 Results 8Health News:Carriage Services Announces Third Quarter 2009 Results 9Health News:Carriage Services Announces Third Quarter 2009 Results 10Health News:Carriage Services Announces Third Quarter 2009 Results 11Health News:Carriage Services Announces Third Quarter 2009 Results 12Health News:Carriage Services Announces Third Quarter 2009 Results 13Health News:Carriage Services Announces Third Quarter 2009 Results 14Health News:Carriage Services Announces Third Quarter 2009 Results 15Health News:Carriage Services Announces Third Quarter 2009 Results 16
... Test is a clinical chemistry assay that ... the cobalt binding capacity of albumin in ... the early 1990s, IMA is produced when ... tissue in the heart. During ischemia, the ...
Inquire...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
Medicine Products: